<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to evaluate the efficacy of prophylaxis using low-dose non-fractioned <z:chebi fb="5" ids="28304">heparin</z:chebi> and aspirin in the prevention of <z:hpo ids='HP_0001511'>intrauterine growth restriction</z:hpo> and <z:hpo ids='HP_0001518'>low birth weights</z:hpo> in patients suffering from <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001511'>Intrauterine growth retardation</z:hpo> and birth weights of 34 gestations involving 28 women with histories of multiple <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> and elevated <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> levels were evaluated in a prospective study in the period from April 1988 to July 2004 </plain></SENT>
<SENT sid="2" pm="."><plain>A control group was formed of 39 women without previous history of <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> over a total of 40 gestations </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001511'>Intrauterine growth retardation</z:hpo> was considered when the weight of the newborn baby was below the tenth percentile for gestational age according to the fetal weight chart </plain></SENT>
<SENT sid="4" pm="."><plain>Diagnosis of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> was achieved using the ELIZA test to measure the IgG and IgM immunoglobulin levels </plain></SENT>
<SENT sid="5" pm="."><plain>Evaluation of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was performed using the activated partial thromboplastin time (aPTT) </plain></SENT>
<SENT sid="6" pm="."><plain>Women suffering from <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> underwent prophylactic treatment during gestation with low doses of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> (100 mg daily) associated to low doses of subcutaneous <z:chebi fb="5" ids="28304">heparin</z:chebi> (5000 IU twice daily) </plain></SENT>
<SENT sid="7" pm="."><plain>The non-paired Student t-test, Fisher Exact and Mann-Whitney tests were used for statistical analysis with an a error of up to 5% considered acceptable </plain></SENT>
<SENT sid="8" pm="."><plain>A statistically higher number of newborns suffered <z:hpo ids='HP_0001511'>intrauterine growth retardation</z:hpo> and <z:hpo ids='HP_0001518'>low birth weights</z:hpo> in the study group than in the control group </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, children of mothers suffering from <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, even those undergoing prophylactic treatment with low-dose non-fractioned <z:chebi fb="5" ids="28304">heparin</z:chebi> and aspirin, are associated to <z:hpo ids='HP_0001511'>intrauterine growth retardation</z:hpo> and <z:hpo ids='HP_0001518'>low birth weights</z:hpo> </plain></SENT>
</text></document>